At a glance
Effects
- Cognitive enhancement: A 1996 controlled study in healthy subjects found doses of 250–1,000 µg improved attention and short-term memory, with effects maximised under fatigue conditions [4].
- Neuroprotection / stroke support: In Russian clinical use, Semax is approved for acute ischaemic stroke and traumatic brain injury; a 2018 trial in 110 stroke patients showed increased plasma BDNF and improved rehabilitation timing [4][7].
- BDNF / neurotrophic upregulation: A single 50 µg/kg dose produces a ~1.4-fold increase in BDNF protein and a 3-fold rise in BDNF mRNA in hippocampal tissue in preclinical models [4].
- Mood / anxiolytic potential: Animal studies show antidepressant-like and anxiolytic-like effects via serotonergic and BDNF pathways; small Russian trials report mood-buffering effects, though it is not formally approved for any mood disorder [2][5].
- Fatigue resilience / focus: Some clinicians explore low-dose Semax for cognitive fatigue, ADHD, and 'brain fog', aiming to improve focus and reduce mental fatigue [7].
Synthetic neuropeptide / nootropic (ACTH fragment analogue)
Parent: ~2–5 min plasma; active metabolite Pro-Gly-Pro extends functional effects to hours [6]
Intranasal (primary); subcutaneous studied in animals; oral bioavailability is effectively zero [6]
Approved pharmaceutical in Russia/CIS; not FDA/EMA approved — research compound only in US, UK, EU [2][5]
CSF concentrations rise within ~30 minutes of intranasal dose [6]
About Semax
Every point here is drawn from public medical and harm-reduction sources. A bracketed number after a claim — like [1]— is a reference: tap it to open the exact source it's based on (numbered list at the bottom). It is not a rating or score. Educational information, not medical advice.
Product specifics
- Est. delivery
- 3–7 business days · EU tracked
Product details as stated by the vendor (claims, not independently verified). Delivery is our standard EU estimate.
What it is
Semax is a synthetic heptapeptide nootropic derived from a fragment of adrenocorticotropic hormone (ACTH), developed in Russia in the late 1980s for neuroprotection, cognitive enhancement, and stroke recovery [1]. It is registered as a pharmaceutical in Russia and several CIS countries but is not approved by the FDA, EMA, or equivalent agencies in the US, UK, or EU, where it circulates as a research compound [2].
How it works
Semax works through multiple overlapping mechanisms centred on neurotrophin signalling [1]. It rapidly upregulates BDNF (brain-derived neurotrophic factor) and NGF in the hippocampus and frontal cortex, activating TrkB receptor pathways that drive synaptic plasticity, long-term potentiation, and neuronal survival [2][3]. Simultaneously it activates dopaminergic and serotonergic brain systems, and inhibits enkephalin-degrading enzymes, prolonging endogenous opioid signalling [4][5]. The parent peptide has a plasma half-life of only 2–5 minutes, but it is metabolised to the active fragment Pro-Gly-Pro, which accumulates in brain tissue and extends functional effects well beyond the parent molecule's clearance [6]. Oral bioavailability is effectively zero because gastric peptidases destroy the peptide on contact; intranasal delivery bypasses this and provides partial direct nose-to-brain transport via olfactory and trigeminal pathways [6].
Risks & side effects
Most important: The most significant risk is the near-total absence of independent Western pharmacovigilance, long-term safety data, and quality control: research-grade Semax is not manufactured under pharmaceutical GMP standards, creating real risk of mislabelled, degraded, or contaminated product [8][9]. Users with anxiety disorders, uncontrolled hypertension, seizure history, or psychiatric conditions should not use Semax without specialist oversight, as dopaminergic potentiation and CNS excitatory effects carry uncharacterised risks in these populations [8][10].
Common
Serious
- Amplified anxiety or agitation in predisposed individuals — a 1996 study documented an anxiogenic component in some subjects [8]
- Blood-pressure elevation — caution advised in patients with uncontrolled hypertension or unstable cardiovascular disease [10]
- Unknown interactions with SSRIs, SNRIs, MAOIs, and stimulants via shared monoaminergic pathways [8][10]
- Degraded or contaminated product from unverified research-compound suppliers [9]
Rare
- Theoretical CNS excitatory risk in individuals with seizure history — melanocortin receptor modulation carries uncharacterised excitatory potential [8]
- Theoretical concern with active neuroendocrine malignancy due to ACTH-fragment analogy [8]
- Unknown fetal/infant effects — no reproductive or developmental toxicology data exist [8][12]
Safety & harm reduction
- Pregnancy or breastfeeding — no reproductive or developmental toxicology data exist [8][12]
- Known hypersensitivity to Semax or any formulation component [7][10]
- Active or history of seizure disorder — theoretical CNS excitatory risk via melanocortin receptor modulation [8]
- Severe nasal septum damage (for intranasal use) [7]
- Active neuroendocrine malignancy — ACTH-fragment analogue; theoretical concern [8]
- Neuropsychiatric status: assess at baseline and during use, especially in individuals with mood or anxiety disorders [1]
- Blood pressure: caution advised in patients with hypertension or cardiovascular disease [10]
- Sleep quality: administer earlier in the day and monitor for insomnia [11]
- Renal / hepatic function: pharmacokinetics under organ impairment are uncharacterised; caution in liver or kidney disease [12]
- SSRIs, SNRIs, MAOIs — Semax modulates serotonergic systems; combine only with clinician oversight [8]
- Stimulants (amphetamines, etc.) — Semax potentiates dopaminergic activity; additive CNS stimulation risk [8][4]
- Other nootropics — avoid stacking when new to Semax; interaction data are very limited [13]
- Sleep medications — late-day dosing may oppose sedative effects [11]
- Store reconstituted solution refrigerated at 2–8 °C; use within 28–30 days; temperature excursions degrade potency without visible change [6][9]
- Administer intranasally onto nasal mucosa with head slightly tilted back to avoid throat drainage [5]
- Source only from GMP-certified suppliers with third-party purity and low-endotoxin testing [7]
- Discard any cloudy or particulate solutions [7]
- If cycling, allow a rest period at least equivalent to the course duration before restarting [3]
Dosage context
Commonly reported ranges (not a prescription; always seek medical guidance). Russian clinical formulations are 0.1% or 1% intranasal drops [5]. For cognitive enhancement, typical protocols report 1–2 drops per nostril twice daily for 10–14 days [5]. For nootropic use, community-reported doses run 250–600 µg/day intranasally, starting at 300 µg/day and titrating up [3]. A full research dose of 500–1,000 µg/day for up to 30–60 days has been referenced in harm-reduction literature, with rest periods afterwards [3]. Stroke protocols in Russian practice used up to 6,000 µg/day under medical supervision [5][8]. Individual variability is significant; start low and monitor [10].
Sources
- 1.Newtropin — Semax: Mechanisms, Research & Clinical Overview
- 2.Wikipedia — Semax
- 3.Peptides.org — Semax Side Effects
- 4.Medsbase — Semax Peptide: Nootropic, BDNF & The Honest Science
- 5.Swolverine — Semax Dosing Guide
- 6.Parahealth — Semax Dosing Guide: Intranasal Research Protocols
- 7.Helimeds — Semax Peptide Dosage Guide
- 8.Peptide Protocol Wiki — Semax Side Effects & Safety Review 2026
- 9.PeptideFox — Semax: Neuroprotection & Cognitive Enhancement
- 10.Synapse (PatSnap) — Semax Side Effects
- 11.Synapse (PatSnap) — What is Semax Used For?
- 12.Superpower.com — Semax: ACTH(4-7)-Derived Heptapeptide
- 13.Wholisticresearch — Semax: Nootropic Benefits, Dosage & Side Effects
This information is provided for educational and harm-reduction purposes only. It is not medical advice. These substances can carry serious health risks; effects and safe use vary by individual. Consult a qualified healthcare professional before use. Legal status varies by country — it is your responsibility to know your local law. We do not encourage misuse.